<DOC>
	<DOCNO>NCT01148043</DOCNO>
	<brief_summary>The purpose study determine efficacy hydroxychloroquine hand osteoarthritis .</brief_summary>
	<brief_title>Pharmacological Treatment In Osteoarthritis</brief_title>
	<detailed_description>Osteoarthritis common joint disease , frequently involve hand , result pain , stiffness loss hand function . At present , option prevent onset progression hand osteoarthritis ( OA ) . It believe inflammation play important role pathogenesis OA anti-inflammatory drug might effective treatment OA . Anti-malarial agent like chloroquine hydroxychloroquine potential anti-inflammatory drug hydroxychloroquine already proven effective suppressor inflammation rheumatoid arthritis . Several previous study hydroxychloroquine hand OA also show possible effect pain inflammation , study mostly retrospective small number patient . This first prospective , randomised , placebo-controlled study determine effect hydroxychloroquine hand osteoarthritis .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Age ≥ 40 year Primary hand OA accord ACR classification Heberden Bouchard nodule KellgrenLawrence grade 1 , 2 3 change ≥ 2 symptomatic joint Pain dominant hand ≥ 12 month Use NSAID ≥ 1 episode pain Written inform consent Secondary hand OA , e.g . haemochromatoses , rheumatoid arthritis , posttraumatic KellgrenLawrence grade 4 OA Use hydroxychloroquine within 3 month enter study Use NSAIDs corticosteroid within 7 day enter study Retinopathy Myasthenia gravis Known allergy hypersensitivity hydroxychloroquine</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>